Correlation Between Enanta Pharmaceuticals and Pulmatrix
Can any of the company-specific risk be diversified away by investing in both Enanta Pharmaceuticals and Pulmatrix at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Enanta Pharmaceuticals and Pulmatrix into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Enanta Pharmaceuticals and Pulmatrix, you can compare the effects of market volatilities on Enanta Pharmaceuticals and Pulmatrix and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Enanta Pharmaceuticals with a short position of Pulmatrix. Check out your portfolio center. Please also check ongoing floating volatility patterns of Enanta Pharmaceuticals and Pulmatrix.
Diversification Opportunities for Enanta Pharmaceuticals and Pulmatrix
-0.81 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Enanta and Pulmatrix is -0.81. Overlapping area represents the amount of risk that can be diversified away by holding Enanta Pharmaceuticals and Pulmatrix in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Pulmatrix and Enanta Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Enanta Pharmaceuticals are associated (or correlated) with Pulmatrix. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Pulmatrix has no effect on the direction of Enanta Pharmaceuticals i.e., Enanta Pharmaceuticals and Pulmatrix go up and down completely randomly.
Pair Corralation between Enanta Pharmaceuticals and Pulmatrix
Given the investment horizon of 90 days Enanta Pharmaceuticals is expected to under-perform the Pulmatrix. But the stock apears to be less risky and, when comparing its historical volatility, Enanta Pharmaceuticals is 1.83 times less risky than Pulmatrix. The stock trades about -0.08 of its potential returns per unit of risk. The Pulmatrix is currently generating about 0.11 of returns per unit of risk over similar time horizon. If you would invest 178.00 in Pulmatrix on November 2, 2024 and sell it today you would earn a total of 592.00 from holding Pulmatrix or generate 332.58% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Enanta Pharmaceuticals vs. Pulmatrix
Performance |
| Timeline |
| Enanta Pharmaceuticals |
| Pulmatrix |
Enanta Pharmaceuticals and Pulmatrix Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Enanta Pharmaceuticals and Pulmatrix
The main advantage of trading using opposite Enanta Pharmaceuticals and Pulmatrix positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Enanta Pharmaceuticals position performs unexpectedly, Pulmatrix can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Pulmatrix will offset losses from the drop in Pulmatrix's long position.| Enanta Pharmaceuticals vs. Monte Rosa Therapeutics | Enanta Pharmaceuticals vs. Design Therapeutics | Enanta Pharmaceuticals vs. Werewolf Therapeutics | Enanta Pharmaceuticals vs. Ikena Oncology |
| Pulmatrix vs. Capricor Therapeutics | Pulmatrix vs. Akari Therapeutics PLC | Pulmatrix vs. Soleno Therapeutics | Pulmatrix vs. Bio Path Holdings |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Volatility Analysis module to get historical volatility and risk analysis based on latest market data.
Other Complementary Tools
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. |